IMPACT OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RISK IN PATIENTS TREATED WITH UPADACITINIB VERSUS COMPARATORS: POST HOC ANALYSIS OF THE SELECT RHEUMATOID ARTHRITIS PROGRAM

被引：0
|
作者：
Charles-Schoeman, C. [1 ]
Buch, M. H. [2 ,3 ]
Burmester, G. R. [4 ]
Liu, J. [5 ]
Dilley, D. [5 ]
Palac, H. [5 ]
Strengholt, S. [5 ]
Curtis, J. [6 ]
机构：
[1] Univ Calif Los Angeles, Div Rheumatol, Dept Med, Los Angeles, CA USA
[2] Univ Manchester, Manchester, Lancs, England
[3] NIHR Manchester Biomed Res Ctr, Ctr Musculoskeletal Res, Fac Biol Med & Hlth, Manchester, Lancs, England
[4] Charite Univ Med Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany
[5] AbbVie, Immunol, N Chicago, IL USA
[6] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Safety; Targeted synthetic drugs; Cardiovascular disease;
D O I：
10.1136/annrheumdis-2023-eular.3337
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0828
引用
收藏
页码：711 / 712
页数：2
相关论文
共 50 条
  • [21] SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM
    Cohen, Stanley B.
    van Vollenhoven, Ronald
    Winthrop, Kevin
    Zerbini, Cristiano
    Tanaka, Yoshiya
    Bessette, Louis
    Li Yihan
    Khan, Nasser
    Hendrickson, Barbara
    Burmester, Gerd Ruediger
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 357 - 357
  • [22] INTEGRATED LABORATORY ABNORMALITY PROFILES OF UPADACITINIB WITH UP TO 4.5 YEARS OF EXPOSURE IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED IN THE SELECT PHASE 3 PROGRAM
    Charles-Schoeman, C.
    Giles, J. T.
    Lane, N.
    Choy, E.
    Furst, D.
    Vencovsky, J.
    Wilson, A. G.
    Burmester, G. R.
    Shaw, T.
    Song, Y.
    Camp, H.
    Khan, N.
    Yee, J.
    Anyanwu, S.
    Mcinnes, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 72 - 73
  • [23] SAFETY PROFILE OF UPADACITINIB IN RHEUMATOID ARTHRITIS: INTEGRATED ANALYSIS FROM THE SELECT PHASE 3 CLINICAL PROGRAM
    Cohen, Stanley B.
    van Vollenhoven, Ronald
    Winthrop, Kevin
    Zerbini, Cristiano A. F.
    Tanaka, Yoshiya
    Bessette, Louis
    Zhang, Ying
    Khaff, Nasser
    Hendrickson, Barbara
    Enejosa, Jeffrey V.
    Burmesters, Gerd
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 : 10 - 10
  • [24] Safety Profile of Upadacitinib in Rheumatoid Arthritis: Integrated Analysis from the SELECT Phase 3 Clinical Program
    Cohen, Stanley
    van Vollenhoven, Ronald
    Winthrop, Kevin
    Zerbini, Cristiano A.
    Tanaka, Yoshiya
    Bessette, Louis
    Zhang, Ying
    Khan, Nasser
    Hendrickson, Barbara
    Enejosa, Jose Jeffrey
    Burmester, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [25] Risk factors for venous thromboembolism and atherosclerotic cardiovascular disease: do they differ in patients with rheumatoid arthritis?
    Ozen, Gulsen
    Pedro, Sofia
    Schumacher, Rebecca
    Simon, Teresa
    Michaud, Kaleb
    RMD OPEN, 2021, 7 (02):
  • [26] Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis
    Martin Soubrier
    Jinglan Pei
    Frédérick Durand
    Lars Gullestad
    Ani John
    Rheumatology and Therapy, 2017, 4 : 133 - 149
  • [27] Concomitant Use of Statins in Tocilizumab-Treated Patients with Rheumatoid Arthritis: A Post Hoc Analysis
    Soubrier, Martin
    Pei, Jinglan
    Durand, Frederick
    Gullestad, Lars
    John, Ani
    RHEUMATOLOGY AND THERAPY, 2017, 4 (01) : 133 - 149
  • [28] Impact of Upadacitinib versus Abatacept on Individual Disease Outcomes in Patients with Rheumatoid Arthritis and Inadequate Responses to Biologic DMARDs
    van Vollenhoven, Ronald
    Rubbert-Roth, Andrea
    Hall, Stephen
    Xavier, Ricardo
    Shmagel, Anna K.
    Song, Yanna
    Anyanwu, Samuel
    Strand, Vibeke
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2812 - 2814
  • [29] Relationship Between Disease Activity and Adverse Events in Rheumatoid Arthritis: An Integrated Post Hoc Analysis of Upadacitinib Phase 3 Trials
    Fleischmann, Roy
    Szekanecz, Zoltan
    Mysler, Eduardo
    Winthrop, Kevin
    Yamaoka, Kunihiro
    Famulla, Kirsten
    Song, Yanna
    Kovacs, Birgit
    Strengholt, Sander
    Burmester, Gerd
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 2836 - 2839
  • [30] The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysis
    Lovering, Edward
    Kodishala, Chanakya
    George, Roslin Jose
    Kumar, Rakesh
    Crowson, Cynthia S.
    Lennon, Ryan J.
    Davis III, John M.
    Myasoedova, Elena
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2024, 69
12345